Behavioural variant frontotemporal dementia--defining genetic and pathological subtypes.

Area of Science:

• Neuroscience
• Neurology
• Pathology

Background:

• Behavioural variant frontotemporal dementia (bvFTD) is a heterogeneous neurodegenerative disorder.
• It is characterized by behavioral changes, cognitive deficits, and frontal/temporal lobe atrophy.
• Current diagnostic methods lack clear correlation between clinical presentation and underlying pathology (FTLD-tau, FTLD-TDP, FTLD-FUS).

Purpose of the Study:

• To review current and future biomarkers for in-life pathological diagnosis of bvFTD.
• To differentiate between bvFTD-tau, bvFTD-TDP, and bvFTD-FUS.

Main Methods:

• Review of existing literature on bvFTD biomarkers.
• Analysis of clinical, neuropsychological, neuroimaging, blood, and cerebrospinal fluid (CSF) markers.
• Exploration of emerging diagnostic technologies.

Main Results:

• No clear correlation currently exists between clinical/neuroanatomical phenotype and specific pathology.
• Biomarkers are essential for accurate in-life pathological diagnosis.
• Various markers including imaging and fluid biomarkers show promise.

Conclusions:

• Accurate in-life pathological diagnosis of bvFTD subtypes is increasingly important for clinical trials and treatment.
• Further research into combined biomarker approaches is needed.
• Development of reliable biomarkers will improve patient management and therapeutic strategies.